Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
2.
Respir Care ; 62(2): 137-143, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28108683

ABSTRACT

BACKGROUND: Multidisciplinary tracheostomy teams have been successful in improving operative outcomes; however, limited data exist on their effect on postoperative care. We aimed to determine the effectiveness of a multidisciplinary tracheostomy service alone and following implementation of a post-tracheostomy care bundle on rates of decannulation and tolerance of oral diet before discharge. METHODS: Prospective data on all subjects requiring tracheostomy by any trauma/critical care surgeon were collected from January 2011 to December 2013 following development of a tracheostomy service and continued following implementation of the post-tracheostomy care bundle. Rates of decannulation and tolerance of oral diet were compared between all groups: pre-tracheostomy service (baseline, historical control), tracheostomy service alone, and tracheostomy service with post-tracheostomy care bundle. RESULTS: Three hundred ninety-three subjects met the criteria for analysis with 61 in the baseline group, 124 following initiation of a tracheostomy service, and 208 after the addition of the post-tracheostomy care bundle. There were significant overall differences between all groups in the proportion of subjects decannulated, proportion of subjects tolerating oral diet, and number of subjects receiving speech evaluations. Pairwise comparisons showed no differences in decannulation or tolerance of oral diet following implementation of the tracheostomy service alone but significant improvement with the addition of the post-tracheostomy care bundle compared with baseline. (P = .002 and P = .005, respectively). Likewise, the number of speech language pathologist consults significantly increased compared with baseline only after the post-tracheostomy care bundle (P = .004). Time to speech evaluation significantly decreased with the post-tracheostomy care bundle compared with baseline and tracheostomy service (P < .013). CONCLUSIONS: The addition of a post-tracheostomy care bundle to a multidisciplinary tracheostomy service significantly improved rates of decannulation and tolerance of oral diet.


Subject(s)
Postoperative Care/methods , Respiratory Therapy , Speech-Language Pathology , Tracheostomy/adverse effects , Adult , Aged , Deglutition , Eating , Female , Humans , Male , Middle Aged , Patient Care Bundles , Prospective Studies , Referral and Consultation , Respiratory Therapy Department, Hospital/organization & administration
3.
Am J Surg ; 206(4): 488-93, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23806826

ABSTRACT

BACKGROUND: Functional outcomes can improve with early intensive care unit (ICU) mobilization programs but require additional resources. Details regarding resource allotment and methods to deliver therapy are lacking. We describe an effective team-based, resource-efficient mobility program (REMP). METHODS: Consecutive admissions (November 2009 to March 2010) underwent an evaluation by a physical therapist and participation in the REMP. Sitting balance (SB), transfer from bed to chair, and ambulation were assessed on the initial evaluation and compared with ICU and hospital discharge using the Functional Independence Measure scale. RESULTS: Twenty-eight patients entered the REMP, and 31 patients served as controls. There were no differences in baseline characteristics or initial Functional Independence Measure scores for ambulation or SB. Bed-to-chair evaluation was higher in the controls (P < .024). Both groups improved across the 3 time periods on all measures; however, more REMP patients had a significantly improved SB at ICU and hospital discharge. CONCLUSIONS: A team-based, resource-efficient approach to early mobilization is feasible and effective in the ICU.


Subject(s)
Critical Illness/rehabilitation , Early Ambulation , Intensive Care Units , Patient Care Team , Aged , Case-Control Studies , Disability Evaluation , Female , Humans , Male , Middle Aged , Outcome and Process Assessment, Health Care , Physical Therapy Modalities , Program Evaluation , Quality Improvement
4.
Am J Surg ; 205(4): 414-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23375703

ABSTRACT

BACKGROUND: Blunt hollow viscus injury (BHVI) is challenging to diagnose. The purpose of this study was to determine the reliability of physical exam and the role of computed tomography (CT) in the diagnosis of BHVI. METHODS: All blunt abdominal trauma (BAT) admissions to a level 1 trauma center from January 2009 through December 2011 were identified through the trauma registry. Data collected included demographics and findings on CT and physical exam. RESULTS: Of 2,912 patients with blunt trauma, 340 had BAT, and 30 (9%) had BHVIs. The sensitivity and specificity of CT were 86% and 88%, respectively, whereas the sensitivity and specificity of clinical exam were 53% and 69%. Twenty-seven percent of patients with BAT and bladder injuries had concomitant BHVIs. CONCLUSIONS: This is the largest single series of BHVI after BAT. CT is superior to clinical exam in establishing the diagnosis of BHVI. Although associated injuries are common, bladder injury may be an important marker for BHVI.


Subject(s)
Abdominal Injuries/diagnosis , Intestines/injuries , Multidetector Computed Tomography , Physical Examination , Stomach/injuries , Wounds, Nonpenetrating/diagnosis , Abdominal Injuries/diagnostic imaging , Abdominal Injuries/etiology , Adult , Female , Humans , Intestines/diagnostic imaging , Male , Middle Aged , Registries , Reproducibility of Results , Retrospective Studies , Risk Factors , Sensitivity and Specificity , Stomach/diagnostic imaging , Urinary Bladder/diagnostic imaging , Urinary Bladder/injuries , Wounds, Nonpenetrating/diagnostic imaging , Wounds, Nonpenetrating/etiology
6.
Arch Surg ; 146(5): 552-5, 2011 May.
Article in English | MEDLINE | ID: mdl-21576610

ABSTRACT

OBJECTIVE: To determine the impact of standardized critical care documentation tools on charge capture by intensive care unit (ICU) advanced practitioners (APs). DESIGN: Prospective charge capture analysis of AP critical care charges (Current Procedural Terminology codes 99291 or 99292). SETTING: Neurosurgical, general surgical, and cardiothoracic ICUs in a level I, 800-bed hospital. The AP provider to patient ratio was 1:6, with 24-hour surgical intensivist oversight. PARTICIPANTS: Advanced practice registered nurses and physician assistants in the ICU. INTERVENTIONS: Standardized templates were developed to simplify documentation and optimize billing of critical care. All APs participated in comprehensive educational sessions on billing compliance and documentation. MAIN OUTCOME MEASURES: Charge capture was collected for 3 years, and comparisons were made between the first quarter before (fiscal year [FY] 2008), during (FY 2009) and after (FY 2010) implementation. The number of ICU patient-days, length of stay, and of beds was collected. RESULTS: During the implementation/education phase (FY 2009), there were no differences in charge capture compared with FY 2008. Each unit demonstrated an increase in charge capture after implementation, and an overall increase of 48% for all 3 ICUs was seen. The number of admissions and length of stay were not statistically different. The total number of ICU beds increased from 42 to 45 during the evaluation period. The salary offset for APs increased from 62% to 80%. CONCLUSIONS: Advanced practitioners represent an important component of the critical care services provided to patients in high-acuity surgical ICUs. Standardized critical care documentation and comprehensive education on evaluation and management guidelines significantly increased charge capture.


Subject(s)
Advanced Practice Nursing/economics , Documentation/standards , Hospital Charges/statistics & numerical data , Inservice Training/standards , Intensive Care Units/economics , Nurse Practitioners/economics , Physician Assistants/economics , Connecticut , Cost-Benefit Analysis/statistics & numerical data , Current Procedural Terminology , Hospital Bed Capacity/economics , Hospital Costs/statistics & numerical data , Humans , Patient Credit and Collection/economics , Prospective Studies
7.
Am J Physiol Heart Circ Physiol ; 300(2): H522-6, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21131482

ABSTRACT

The role of other STAT subtypes in conferring ischemic tolerance is unclear. We hypothesized that in STAT-3 deletion alternative STAT subtypes would protect myocardial function against ischemia-reperfusion injury. Wild-type (WT) male C57BL/6 mice or mice with cardiomyocyte STAT-3 knockout (KO) underwent baseline echocardiography. Langendorff-perfused hearts underwent ischemic preconditioning (IPC) or no IPC before ischemia-reperfusion. Following ex vivo perfusion, hearts were analyzed for STAT-5 and -6 phosphorylation by Western blot analysis of nuclear fractions. Echocardiography and postequilibration cardiac performance revealed no differences in cardiac function between WT and KO hearts. Phosphorylated STAT-5 and -6 expression was similar in WT and KO hearts before perfusion. Contractile function in WT and KO hearts was significantly impaired following ischemia-reperfusion in the absence of IPC. In WT hearts, IPC significantly improved the recovery of the maximum first derivative of developed pressure (+dP/dtmax) compared with that in hearts without IPC. IPC more effectively improved end-reperfusion dP/dtmax in WT hearts compared with KO hearts. Preconditioned and nonpreconditioned KO hearts exhibited increased phosphorylated STAT-5 and -6 expression compared with WT hearts. The increased subtype activation did not improve the efficacy of IPC in KO hearts. In conclusion, baseline cardiac performance is preserved in hearts with cardiac-restricted STAT-3 deletion. STAT-3 deletion attenuates preconditioning and is not associated with a compensatory upregulation of STAT-5 and -6 subtypes. The activation of STAT-5 and -6 in KO hearts following ischemic challenge does not provide functional compensation for the loss of STAT-3. JAK-STAT signaling via STAT-3 is essential for effective IPC.


Subject(s)
Ischemic Preconditioning, Myocardial , STAT Transcription Factors/physiology , STAT3 Transcription Factor/physiology , Animals , Blotting, Western , Coronary Circulation/physiology , Echocardiography , Gene Deletion , Heart/physiology , Hemodynamics/physiology , Janus Kinases/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myocardial Contraction/physiology , Phosphorylation , STAT5 Transcription Factor/physiology
8.
Am Surg ; 75(11): 1100-3, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19927514

ABSTRACT

A significant portion of patients sustaining traumatic brain injury (TBI) take antiplatelet medications (aspirin or clopidogrel), which have been associated with increased morbidity and mortality. In an attempt to alleviate the risk of increased bleeding, platelet transfusion has become standard practice in some institutions. This study was designed to determine if platelet transfusion reduces mortality in patients with TBI on antiplatelet medications. Databases from two Level I trauma centers were reviewed. Patients with TBI 50 years of age or older with documented preinjury use of clopidogrel or aspirin were included in our cohort. Patients who received platelet transfusions were compared with those who did not to assess outcome differences between them. Demographics and other patient characteristics abstracted included Injury Severity Score, Glasgow Coma Scale, hospital length of stay, and warfarin use. Three hundred twenty-eight patients comprised the study group. Of these patients, 166 received platelet transfusion and 162 patients did not. Patients who received platelets had a mortality rate of 17.5 per cent (29 of 166), whereas those who did not receive platelets had a mortality rate of 16.7 per cent (27 of 162) (P = 0.85). Transfusion of platelets in patients with TBI using antiplatelet therapy did not reduce mortality.


Subject(s)
Craniocerebral Trauma/mortality , Intracranial Hemorrhage, Traumatic/therapy , Platelet Aggregation Inhibitors/therapeutic use , Platelet Transfusion/methods , Thrombosis/prevention & control , Aged , Craniocerebral Trauma/complications , Craniocerebral Trauma/diagnosis , Female , Follow-Up Studies , Humans , Intracranial Hemorrhage, Traumatic/complications , Intracranial Hemorrhage, Traumatic/mortality , Male , Middle Aged , Prognosis , Retrospective Studies , Risk Factors , Survival Rate/trends , Thrombosis/complications , Trauma Severity Indices , United States/epidemiology
9.
J Trauma ; 67(1): 91-5; discussion 95-6, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19590315

ABSTRACT

BACKGROUND: Our goal was to define risk factors for ventilator-associated pneumonia (VAP) relapse and examine the implications, if any, for initial therapy in trauma patients. METHODS: Trauma patients cared for in the surgical intensive care unit during a 48-month period with confirmed VAP recurrence were evaluated. Recurrent VAP was defined as a positive quantitative culture (> or = 10(4) colony-forming units/mL in a bronchoalveolar lavage or protected catheter lavage specimen) > or = 4 days after initiation of antibiotics for the primary episode. Recurrence with at least one of the initial causative pathogens was defined as a relapse. Initial causal pathogen, Acute Physiology and Chronic Health Evaluation II score, injury severity score, Glasgow Coma Score (GCS), age, white blood cell count (WBC), and duration of hospital stay before diagnosis were analyzed in univariate and multivariate regression models. RESULTS: A total of 55 patients met the criteria of recurrent VAP. Of these 55 recurrences, 19 (35%) were relapses. Acute Physiology and Chronic Health Evaluation II score, injury severity score, and GCS were not associated with VAP relapse by univariate analyses. Patients who relapsed had primary VAP involving nonfermenting gram-negative bacilli (NFGNB) (Acinetobacter, Pseudomonas, and Stenotrophomonas species) more frequently than other organisms (68% vs. 32%, p = 0.001). Primary VAP with NFGNB was found to be a significant predictor of VAP relapse by univariate and multivariate logistic regression analysis (OR = 5.1, p = 0.003; OR = 4.63, p = 0.005, respectively). CONCLUSIONS: There is a high rate of VAP relapse associated with primary infection by NFGNB, suggesting initial treatment failure. Trauma patients with primary VAP involving these organisms may benefit from increased surveillance for relapse.


Subject(s)
Pneumonia, Ventilator-Associated/epidemiology , Respiration, Artificial/adverse effects , Risk Assessment/methods , Wounds and Injuries/therapy , Anti-Bacterial Agents/therapeutic use , Bacteria/isolation & purification , Bronchoalveolar Lavage Fluid/microbiology , Female , Follow-Up Studies , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/epidemiology , Gram-Negative Bacterial Infections/etiology , Humans , Incidence , Male , Middle Aged , Ohio/epidemiology , Pneumonia, Ventilator-Associated/drug therapy , Pneumonia, Ventilator-Associated/etiology , Retrospective Studies , Risk Factors , Secondary Prevention , Survival Rate/trends
10.
Surgery ; 144(4): 598-603; discussion 603-5, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18847644

ABSTRACT

BACKGROUND: More elderly trauma patients are identified with preinjury use of clopidogrel, aspirin, or warfarin (CAW). The purpose of this study was to determine whether preinjury CAW use was an important predictor of mortality in patients aged >or=50 years with blunt, hemorrhagic brain injury (HBI). METHODS: A retrospective review of patients with blunt, HBI aged >or=50 years with subgroup analysis for older (>70 years) and younger (50-70 years) patients was performed. CAW use was analyzed for differences in age, gender, hospital length of stay (LOS), Injury Severity Score (ISS), Glasgow Coma Score (GCS), mechanism of injury (MOI), platelet transfusion therapy (PLT), disposition at discharge, and in-hospital mortality. RESULTS: From January 2003 to October 2005, 416 patients were identified. The mean age was 69+/-1 years. No differences were found for ISS (24 +/- 0.5), GCS (12 +/- 0.2), or LOS (8 +/- 0.4 days). CAW use was present in 40% of patients and significantly higher in older patients. Mortality was not different between older and younger CAW(+) patients, but it significantly increased for older CAW(-) patients. Significant predictors of death included age, ISS, and GCS (P<.02). CONCLUSIONS: Preinjury CAW use in older blunt, HBI patients is not associated with increased mortality. Age was a significant predictor of mortality independent of CAW use.


Subject(s)
Anticoagulants/administration & dosage , Brain Hemorrhage, Traumatic/mortality , Cardiovascular Diseases/drug therapy , Cardiovascular Diseases/epidemiology , Cause of Death , Platelet Aggregation Inhibitors/administration & dosage , Wounds, Nonpenetrating/mortality , Age Factors , Aged , Anticoagulants/adverse effects , Aspirin/administration & dosage , Aspirin/adverse effects , Brain Hemorrhage, Traumatic/diagnosis , Brain Hemorrhage, Traumatic/surgery , Clopidogrel , Cohort Studies , Comorbidity , Female , Follow-Up Studies , Geriatric Assessment , Hospital Mortality/trends , Humans , Injury Severity Score , Male , Middle Aged , Platelet Aggregation Inhibitors/adverse effects , Preoperative Care , Retrospective Studies , Risk Assessment , Sex Factors , Survival Analysis , Ticlopidine/administration & dosage , Ticlopidine/adverse effects , Ticlopidine/analogs & derivatives , Trauma Centers , Treatment Outcome , Warfarin/administration & dosage , Warfarin/adverse effects , Wounds, Nonpenetrating/diagnosis , Wounds, Nonpenetrating/therapy
11.
Surgery ; 144(4): 670-5; discussion 675-6, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18847653

ABSTRACT

BACKGROUND: Falling reimbursement rates for trauma care demand a concerted effort of charge capture for the fiscal survival of trauma surgeons. We compared current procedure terminology code distribution and billing patterns for Subsequent Hospital Care (SHC) before and after the institution of standardized documentation. METHODS: Standardized SHC progress notes were created. The note was formulated with an emphasis on efficiency and accuracy. Documentation was completed by residents in conjunction with attendings following standard guidelines of linkage. Year-to-year patient volume, length of stay (LOS), injury severity, bills submitted, coding of service, work relative value units (wRVUs), revenue stream, and collection rate were compared with and without standardized documentation. RESULTS: A 394% average revenue increase was observed with the standardization of SHC documentation. Submitted charges more than doubled in the first year despite a 14% reduction in admissions and no change in length of stay. Significant increases in level II and level III billing and billing volume (P < .05) were sustainable year to year and resulted in an average per patient admission SHC income increase from $91.85 to $362.31. CONCLUSIONS: Use of a standardized daily progress note dramatically increases the accuracy of coding and associated billing of subsequent hospital care for trauma services.


Subject(s)
Fees, Medical , Healthcare Common Procedure Coding System/economics , Hospital Charges/standards , Insurance, Health, Reimbursement/economics , Trauma Centers/economics , Cost-Benefit Analysis , Documentation/economics , Documentation/standards , Female , Financial Management, Hospital/economics , Health Care Surveys , Hospital Charges/trends , Humans , Insurance, Health, Reimbursement/trends , Male , Medical Staff, Hospital/economics , Patient Credit and Collection , Probability , Sensitivity and Specificity , Trauma Centers/statistics & numerical data , Traumatology/economics , United States
12.
Am J Physiol Heart Circ Physiol ; 295(4): H1649-56, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18708442

ABSTRACT

Postconditioning (POC), a novel strategy of cardioprotection against ischemia-reperfusion injury, is clinically attractive because of its therapeutic application at the predictable onset of reperfusion. POC activates several intracellular kinase signaling pathways, including phosphatidylinositol 3-kinase (PI3K)-Akt (RISK). The regulation of POC-induced survival kinase signaling, however, has not been fully characterized. JAK-STAT activation is integral to cardiac ischemic tolerance and may provide upstream regulation of RISK. We hypothesized that POC requires the activation of both JAK-STAT and RISK signaling. Langendorff-perfused mouse hearts were subjected to 30 min of global ischemia and 40 min of reperfusion, with or without POC immediately after ischemia. A separate group of POC hearts was treated with AG 490, a JAK2 inhibitor, Stattic, a specific STAT3 inhibitor, or LY-294002, a PI3K inhibitor, at the onset of reperfusion. Cardiomyocyte-specific STAT3 knockout (KO) hearts were also subjected to non-POC or POC protocols. Myocardial performance (+dP/dt(max), mmHg/s) was assessed throughout each perfusion protocol. Phosphorylated (p-) STAT3 and Akt expression was analyzed by Western immunoblotting. POC enhanced myocardial functional recovery and increased expression of p-STAT3 and p-Akt. JAK-STAT inhibition abrogated POC-induced functional protection. STAT3 inhibition decreased expression of both p-STAT3 and p-Akt. PI3K inhibition also attenuated POC-induced cardioprotection and reduced p-Akt expression but had no effect on STAT3 phosphorylation. Interestingly, STAT3 KO hearts undergoing POC exhibited improved ischemic tolerance compared with KO non-POC hearts. POC induces myocardial functional protection by activating the RISK pathway. JAK-STAT signaling, however, is insufficient for effective POC without PI3K-Akt activation.


Subject(s)
Janus Kinases/metabolism , Myocardial Reperfusion Injury/prevention & control , Myocytes, Cardiac/enzymology , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction , Animals , Chromones/pharmacology , Cyclic S-Oxides/pharmacology , Janus Kinases/antagonists & inhibitors , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Morpholines/pharmacology , Myocardial Contraction , Myocardial Reperfusion Injury/enzymology , Myocardial Reperfusion Injury/physiopathology , Myocytes, Cardiac/drug effects , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Recovery of Function , STAT3 Transcription Factor/antagonists & inhibitors , STAT3 Transcription Factor/deficiency , STAT3 Transcription Factor/genetics , Signal Transduction/drug effects , Time Factors , Tyrphostins/pharmacology , Ventricular Function, Left
13.
Am J Surg ; 195(5): 702-4, 2008 May.
Article in English | MEDLINE | ID: mdl-18424291

ABSTRACT

BACKGROUND: Morbidity and financial loss caused by equine-related injuries may be significant. The purposes of this study were to determine the patterns of equine-related injury and the impact on outcomes. METHODS: A 10-year retrospective review of equine-related injuries was performed. Age, gender, mechanism, injury severity score, Glasgow Coma Score, length of stay, surgical interventions, and mortality were assessed. RESULTS: Of 80 emergency department evaluations, 76 patients were admitted and form the basis of this study. The most frequent mechanism of injury was fall (68%), followed by crush injuries (15%), kicks (8%), and trampling (5%). Musculoskeletal injuries were most common (64%). Thirty-eight (50%) patients required surgical intervention. Thirty-seven (52%) patients were discharged home; 34% required outpatient physical therapy, and 14% required inpatient rehabilitation. The mortality rate was 7%. CONCLUSIONS: Equine-related injuries resulted in significant morbidity; most victims required outpatient or inpatient rehabilitation. The use of preventive strategies may minimize mortality and reduce the financial impact of postinjury morbidity.


Subject(s)
Accidental Falls/statistics & numerical data , Craniocerebral Trauma/epidemiology , Horses , Musculoskeletal System/injuries , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Female , Glasgow Coma Scale , Humans , Injury Severity Score , Length of Stay , Male , Middle Aged , Retrospective Studies
14.
Am J Surg ; 195(2): 159-63, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18096127

ABSTRACT

BACKGROUND: Bronchoalveolar lavage (BAL) is recommended to facilitate the diagnosis of ventilator-associated pneumonia (VAP). It is unclear if bilateral sampling improves the accuracy of BAL. METHODS: Consecutive patients with clinical suspicion for VAP were analyzed. All patients underwent bilateral BAL. A threshold of >10(4) colony-forming units (cfu)/mL was diagnostic for VAP (VAP positive). Samples were concordant if the organism(s) and thresholds from both lungs were diagnostically consistent. Organisms 10(4) cfu/mL were considered false-negative samples. RESULTS: Between November 2005 and April 2006, 73 patients were considered clinically suspicious for VAP. Forty-four (60%) patients were VAP positive. Twenty-eight (64%) VAP patients had concordant samples. Overall, there were 15 false-negative samples. Sole use of the unilateral samples to guide treatment would have inappropriately directed antibiotic avoidance and/or discontinuation in 25% of VAP patients. Influence of the chest radiograph was equivocal because of the presence of bilateral infiltrates in 80% of discordant samples. CONCLUSIONS: Bilateral BAL improves the accuracy of bronchoscopy in diagnosing VAP. Unilateral BAL may be insensitive in patients with clinically significant contralateral infection.


Subject(s)
Bronchoalveolar Lavage Fluid/microbiology , Pneumonia, Bacterial/diagnosis , Respiration, Artificial/adverse effects , Cohort Studies , Colony Count, Microbial , Critical Illness , Cross Infection/diagnosis , Cross Infection/epidemiology , Cross Infection/etiology , Female , Hospital Mortality/trends , Humans , Incidence , Intensive Care Units , Male , Middle Aged , Pneumonia, Bacterial/epidemiology , Pneumonia, Bacterial/etiology , Probability , Respiration, Artificial/methods , Risk Assessment , Sensitivity and Specificity , Surgical Procedures, Operative , Survival Analysis
15.
Am J Physiol Heart Circ Physiol ; 294(1): H257-62, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17982005

ABSTRACT

Preconditioning (PC) protects against ischemia-reperfusion (I/R) injury via the activation of the JAK-STAT pathway. We hypothesized that the mediators responsible for PC can be transferred to naive myocardium through the coronary effluent. Langendorff-perfused hearts from male Sprague-Dawley rats were randomized to paired donor/acceptor protocols with or without PC in the presence or absence of the JAK-2 inhibitor AG-490 (n = 6 for each group). Warmed, oxygenated coronary effluent collected during the reperfusion phases of PC (3 cycles of 5 min ischemia and 5 min reperfusion) was administered to acceptor hearts. The hearts were then subjected to 30 min ischemia and 40 min reperfusion. The left ventricles were analyzed for phosphorylated (p)STAT-1, pSTAT-3, Bax, Bcl, Bcl-X(L)/Bcl-2-associated protein (BAD), and caspase-3 expression by Western blot. A separate group of hearts (n = 6) was analyzed for STAT activation immediately after the transfer of the PC effluent (no I-R). Baseline cardiodynamics were not different among the groups. End-reperfusion maximal change in pressure over time (+dP/dt(max)) was significantly (P < 0.05) improved in acceptor PC (3,637 +/- 199 mmHg/s) and donor PC (4,304 +/- 347 mmHg/s) hearts over non-PC donor (2,020 +/- 363 mmHg/s) and acceptor (2,624 +/- 345 mmHg/s) hearts. Similar differences were seen for minimal change in pressure over time (-dP/dt(min)). STAT-3 activation was significantly increased in donor and acceptor PC hearts compared with non-PC hearts. Conversely, pSTAT-1 and Bax expression was decreased in donor and acceptor PC hearts compared with non-PC hearts. No differences in Bcl, BAD, or caspase-3 expression were observed. Treatment with AG-490 attenuated the recovery of +/-dP/dt in acceptor PC hearts and significantly reduced pSTAT-3 expression. The PC coronary effluent activates JAK-STAT signaling, limits apoptosis, and protects myocardial performance from I/R injury.


Subject(s)
Ischemic Preconditioning, Myocardial , Janus Kinases/metabolism , Myocardial Reperfusion Injury/prevention & control , Myocardium/metabolism , STAT Transcription Factors/metabolism , Signal Transduction , Animals , Apoptosis , Caspase 3/metabolism , Enzyme Activation , In Vitro Techniques , Male , Myocardial Reperfusion Injury/metabolism , Myocardial Reperfusion Injury/pathology , Myocardial Reperfusion Injury/physiopathology , Myocardium/enzymology , Myocardium/pathology , Perfusion , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Rats , Rats, Sprague-Dawley , STAT1 Transcription Factor/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction/drug effects , Time Factors , Tyrphostins/pharmacology , Ventricular Pressure , bcl-2-Associated X Protein/metabolism , bcl-Associated Death Protein/metabolism , bcl-X Protein/metabolism
16.
Am J Surg ; 193(1): 32-9; discussion 40, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17188084

ABSTRACT

Ethical and scientifically sound research requires that any sample population represent the population as a whole. African-Americans suffer disproportionately from cancer, hypertension, and heart failure compared with whites, but they are commonly underrepresented in clinical trials of these diseases. Failure to include African-American subjects in clinical trials prevents generalizability of the results to this population. African-Americans are often underrepresented in clinical research for numerous historic, societal, educational, and economic reasons. Efforts to improve enrollment of African-American subjects requires recognition of the problem, planning, educational efforts, and investigator training. The incidence of heart disease and prostate cancer in African-Americans dictates that these patients be targeted for clinical trials of surgical research. The research team must appreciate the importance of community involvement and support in recruiting African-Americans participants. Additionally, the continued effort to recruit and train African-American investigators must be a priority.


Subject(s)
Black or African American/statistics & numerical data , Clinical Trials as Topic/ethics , Clinical Trials as Topic/methods , Patient Selection/ethics , Adult , Age Distribution , Biomedical Research/ethics , Biomedical Research/statistics & numerical data , Clinical Protocols/classification , Epidemiologic Research Design , Female , Humans , Male , Sex Distribution
17.
Am J Physiol Heart Circ Physiol ; 291(2): H797-803, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16565302

ABSTRACT

The JAK-STAT pathway is activated in the early and late phases of ischemic preconditioning (IPC) in normal myocardium. The role of this pathway and the efficacy of IPC in hypertrophied hearts remain largely unknown. We hypothesized that phosphorylated STAT-3 (pSTAT-3) is necessary for effective IPC in pressure-overload hypertrophy. Male Sprague-Dawley rats 8 wk after thoracic aortic constriction (TAC) or sham operation underwent echocardiography and Langendorff perfusion. Randomized hearts were subjected to 30 min of global ischemia and 120 min of reperfusion with or without IPC in the presence or absence of the JAK-2 inhibitor AG-490 (AG). Functional recovery and STAT activation were assessed. TAC rats had a 31% increase in left ventricular mass (1,347 +/- 58 vs. 1,028 +/- 43 mg, TAC vs. sham, P < 0.001), increased anterior and posterior wall thickness but no difference in ejection fraction compared with sham-operated rats. In TAC, IPC improved end-reperfusion maximum first derivative of developed pressure (+dP/dt(max); 4,648 +/- 309 vs. 2,737 +/- 343 mmHg/s, IPC vs. non-IPC, P < 0.05) and minimum -dP/dt (-dP/dt(min); -2,239 +/- 205 vs. -1,215 +/- 149 mmHg/s, IPC vs. non-IPC, P < 0.05). IPC increased nuclear pSTAT-1 and pSTAT-3 in sham-operated rats but only pSTAT-3 in TAC. AG in TAC significantly attenuated +dP/dt(max) (4,648 +/- 309 vs. 3,241 +/- 420 mmHg/s, IPC vs. IPC + AG, P < 0.05) and -dP/dt(min) (-2,239 +/- 205 vs. -1,323 +/- 85 mmHg/s, IPC vs. IPC + AG, P < 0.05) and decreased only nuclear pSTAT-3. In myocardial hypertrophy, JAK-STAT signaling is important in IPC and exhibits a pattern of STAT activation distinct from nonhypertrophied myocardium. Limiting STAT-3 activation attenuates the efficacy of IPC in hypertrophy.


Subject(s)
Cardiomegaly/physiopathology , Ischemic Preconditioning, Myocardial , Myocardium/metabolism , STAT3 Transcription Factor/metabolism , Animals , Aorta, Thoracic/physiology , Biotransformation/physiology , Blotting, Western , Echocardiography , Hemodynamics/physiology , In Vitro Techniques , Male , Muscle Contraction/physiology , Muscle Proteins/biosynthesis , Muscle Proteins/genetics , Muscle, Smooth, Vascular/physiology , Perfusion , Rats , Rats, Sprague-Dawley
18.
J Trauma ; 57(2): 316-22, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15345979

ABSTRACT

BACKGROUND: Clinical acumen alone is unreliable in establishing a diagnosis of ventilator-associated pneumonia (VAP) and controversy exists over which diagnostic tools should be utilized to confirm a clinical suspicion of VAP. The purpose of this study was to determine the reliability of blind protected specimen brush (PSB) sampling in the diagnosis of VAP and if bilateral PSB sampling is necessary. METHODS: Prospective study comparing blind PSB sampling with bronchoscopic directed PSB sampling in thirty-four consecutive SICU patients with a clinical suspicion of VAP. All patients underwent blind PSB sampling followed by bronchoscopic directed contralateral PSB sampling. RESULTS: Twenty-four of 34 patients (71%) were diagnosed to have VAP. The concordance rate between blind and directed PSB samples was 53% (18/34). When blind PSB was positive (15/34), the contralateral sample yielded a different microorganism in three patients (9%). When blind PSB was negative (19/34), infection was present in the contralateral lung in nine patients (26%). Blind PSB sampling alone was inaccurate in 35% of patients. CONCLUSIONS: The low concordance between blind and directed PSB suggests the need to sample both lung fields. Bilateral PSB sampling can identify unsuspected pathogenic microorganisms in the contralateral lung.


Subject(s)
Biopsy/methods , Bronchoscopy/methods , Cross Infection/diagnosis , Pneumonia, Bacterial/diagnosis , Respiration, Artificial/adverse effects , Specimen Handling/methods , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy/economics , Biopsy/standards , Bronchoalveolar Lavage Fluid/microbiology , Bronchoscopy/economics , Bronchoscopy/standards , Cost-Benefit Analysis , Cross Infection/etiology , Female , Fever/microbiology , Humans , Length of Stay/statistics & numerical data , Leukocytosis/microbiology , Male , Middle Aged , Patient Selection , Pneumonia, Bacterial/etiology , Prospective Studies , Sensitivity and Specificity , Specimen Handling/economics , Specimen Handling/standards , Time Factors , Wounds and Injuries/complications
20.
J Gastrointest Surg ; 7(7): 917-20, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14592668

ABSTRACT

Percutaneous endoscopic gastrostomy (PEG) has been popular since it was introduced in 1980. Gastrostomy tubes left in place for long periods often result in unusual complications. Complications may also result from simply replacing a long-term indwelling tube. Five patients who had gastrostomy tubes in place for as long as 4 years are presented and their complications reviewed. Various methods used in treating these complications are discussed, and suggestions for their prevention are given. Gastrointestinal erosion and jejunal perforation following migration of the gastrostomy tube, persistent abdominal wall sinus tracts, and separation of the flange head with small bowel obstruction were encountered. Reinsertion of a gastrostomy tube through a tract prior to adequate maturation was also noted to lead to complications. Complications may result from gastrostomy tubes left in place for extended periods of time and during replacement procedures. Awareness of such complications along with education of caregivers and timely intervention by the endoscopist may prevent such occurrences. In some cases one can only hope to minimize morbidity.


Subject(s)
Gastrostomy/adverse effects , Intubation, Gastrointestinal/adverse effects , Postoperative Complications/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Female , Gastrostomy/methods , Humans , Male , Middle Aged , Postoperative Complications/prevention & control , Reoperation , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL